Page last updated: 2024-08-23

balsalazide and olsalazine

balsalazide has been researched along with olsalazine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Giaffer, MH; Holdsworth, CD; O'Brien, CJ1
Schroeder, KW1
Cummings, JH; Edmond, LM; Hopkins, MJ; Magee, EA1
Bjorkman, D; Kane, SV; Loftus, EV1
Baker, DE; Kane, S1
Chang, EB; Hanauer, SB; Kles, KA; Musch, MW; Turner, JR; Vavricka, SR1
Sandborn, WJ1
Dhaneshwar, SS1
Kuriyama, A; Matsumura, M; Urushidani, S1

Reviews

7 review(s) available for balsalazide and olsalazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
    Scandinavian journal of gastroenterology. Supplement, 2002, Issue:236

    Topics: Acute Disease; Administration, Oral; Administration, Rectal; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Enema; Humans; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine; Time Factors

2002
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.
    Alimentary pharmacology & therapeutics, 2004, Jan-15, Volume: 19, Issue:2

    Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Double-Blind Method; Humans; Mesalamine; Phenylhydrazines; Randomized Controlled Trials as Topic

2004
The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Reviews in gastroenterological disorders, 2004,Spring, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aminosalicylic Acids; Child; Clinical Trials as Topic; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Labeling; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Product Surveillance, Postmarketing; Sensitivity and Specificity; Sulfasalazine

2004
Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Reviews in gastroenterological disorders, 2006,Spring, Volume: 6, Issue:2

    Topics: Administration, Oral; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Chemoprevention; Clinical Trials as Topic; Colitis, Ulcerative; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mesalamine; Patient Compliance; Phenylhydrazines; Remission Induction; Sulfasalazine

2006
Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.
    World journal of gastroenterology, 2014, Apr-07, Volume: 20, Issue:13

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Clinical Trials as Topic; Colon; Fatty Acids, Omega-3; Heparin, Low-Molecular-Weight; Humans; Inflammatory Bowel Diseases; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine

2014
5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis.
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents; Databases, Bibliographic; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sulfasalazine; Treatment Outcome; Young Adult

2018

Other Studies

3 other study(ies) available for balsalazide and olsalazine

ArticleYear
Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine.
    Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:1

    Topics: Aminosalicylic Acids; Drug Hypersensitivity; Female; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Phenylhydrazines; Sulfapyridine; Sulfasalazine

1992
The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
    Inflammatory bowel diseases, 2003, Volume: 9, Issue:1

    Topics: Amino Acids; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Desulfovibrio; Feces; Fermentation; Fusobacterium; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Mesalamine; Phenylhydrazines; Sulfasalazine; Sulfides

2003
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
    Inflammatory bowel diseases, 2005, Volume: 11, Issue:3

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; Diarrhea; Disease Models, Animal; Gastrointestinal Agents; Ileum; Mesalamine; Phenylhydrazines; Prodrugs; Rabbits; Random Allocation; Sulfasalazine; Tissue Culture Techniques

2005